Baxter Bros Inc Esperion Therapeutics, Inc. Transaction History
Baxter Bros Inc
- $756 Million
- Q4 2024
A detailed history of Baxter Bros Inc transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Baxter Bros Inc holds 15,000 shares of ESPR stock, worth $25,350. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000
Previous 11,000
36.36%
Holding current value
$25,350
Previous $18,000
83.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ESPR
# of Institutions
215Shares Held
129MCall Options Held
1.78MPut Options Held
1.27M-
Wasatch Advisors Inc Salt Lake City, UT24.5MShares$41.4 Million0.27% of portfolio
-
Black Rock Inc. New York, NY14MShares$23.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$19.8 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V89.94MShares$16.8 Million0.44% of portfolio
-
Morgan Stanley New York, NY6.31MShares$10.7 Million0.0% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $112M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...